Nephrologe
Mehr lesenNephrologe
Arztbesuch | preis auf anfrage |
Nephrektomie | $21000 - $23000 |
Prof. Baris Akin ist ein hochgeschätzter Professor für Chirurgie in Istanbul, Türkei, mit Spezialisierung auf Nieren- und Pankreastransplantation. Er erhielt 2004 auf der amerikanischen Transplantationstagung den "Young Investigator Award" und hat in der Türkei über 1200 Nierentransplantationen erfolgreich durchgeführt. Prof. Akin hat eine neue chirurgische Technik für die Spendernephrektomie entwickelt und ist von der American Society of Transplant Surgeons als Transplantationschirurg zertifiziert.
Mehr lesenProf. Baris Akin ist ein hochgeschätzter Professor für Chirurgie in Istanbul, Türkei, mit Spezialisierung auf Nieren- und Pankreastransplantation. Er erhielt 2004 auf der amerikanischen Transplantationstagung den "Young Investigator Award" und hat in der Türkei über 1200 Nierentransplantationen erfolgreich durchgeführt. Prof. Akin hat eine neue chirurgische Technik für die Spendernephrektomie entwickelt und ist von der American Society of Transplant Surgeons als Transplantationschirurg zertifiziert.
2019 - Halen, İstanbul/İstanbul/Türkiye
MEMORIAL BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Nefroloji Uzmanı
2018 - 2023, İstanbul/İstanbul/Türkiye
MEMORIAL ATAŞEHİR HASTANESİ
Nefroloji Uzmanı
2013 - 2018, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2011 - 2013, Batman/Batman/Türkiye
BATMAN DEVLET HASTANESİ
Nefroloji Uzmanı
2008 - 2011, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2007 - 2008, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR DEVLET HASTANESİ
Mecburi Hizmet
2001 - 2002, Artvin/Artvin/Türkiye
ARHAVİ DERECİK TOPLUM SAĞLIK MERKEZİ
Mecburi Hizmet
Mehr lesen2019 - Halen, İstanbul/İstanbul/Türkiye
MEMORIAL BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Nefroloji Uzmanı
2018 - 2023, İstanbul/İstanbul/Türkiye
MEMORIAL ATAŞEHİR HASTANESİ
Nefroloji Uzmanı
2013 - 2018, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2011 - 2013, Batman/Batman/Türkiye
BATMAN DEVLET HASTANESİ
Nefroloji Uzmanı
2008 - 2011, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ
Nefroloji Uzmanı
2007 - 2008, Eskişehir/Eskişehir/Türkiye
ESKİŞEHİR DEVLET HASTANESİ
Mecburi Hizmet
2001 - 2002, Artvin/Artvin/Türkiye
ARHAVİ DERECİK TOPLUM SAĞLIK MERKEZİ
Mecburi Hizmet
Arztbesuch | preis auf anfrage |
Urethroskopische Lithotripsie | $7500 |
Arztbesuch | preis auf anfrage |
Dialyse | $400 - $500 |
Nephrektomie | $10000 - $12000 |
EXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
General Surgeon
2012 - 2019, Diyarbakır/Diyarbakır/Turkey
DİCLE UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2011 - 2012, Van/Van/Turkey
VAN REGIONAL TRAINING AND RESEARCH HOSPITAL
General Surgeon
2009 - 2011, Van/Van/Turkey
HAKKARİ STATE HOSPITAL
General Surgeon
2004 - 2009, Van/Van/Turkey
YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2002 - 2004, Van/Van/Turkey
HACIBEKİR HEALTH CENTER
General Practitioner
*EDUCATION*
2018 - 2019, Diyarbakır/Turkey
Associate Professor
2015, Ohio/USA
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
Neck Dissection Training
2012 - 2018, Diyarbakır/Turkey
Assistant Professor
1996 - 2002, Adana/Turkey
ÇUKUROVA UNIVERSITY
FACULTY OF MEDICINE - Medical Doctor Education
Mehr lesenEXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
General Surgeon
2012 - 2019, Diyarbakır/Diyarbakır/Turkey
DİCLE UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2011 - 2012, Van/Van/Turkey
VAN REGIONAL TRAINING AND RESEARCH HOSPITAL
General Surgeon
2009 - 2011, Van/Van/Turkey
HAKKARİ STATE HOSPITAL
General Surgeon
2004 - 2009, Van/Van/Turkey
YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2002 - 2004, Van/Van/Turkey
HACIBEKİR HEALTH CENTER
General Practitioner
*EDUCATION*
2018 - 2019, Diyarbakır/Turkey
Associate Professor
2015, Ohio/USA
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
Neck Dissection Training
2012 - 2018, Diyarbakır/Turkey
Assistant Professor
1996 - 2002, Adana/Turkey
ÇUKUROVA UNIVERSITY
FACULTY OF MEDICINE - Medical Doctor Education
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Mehr lesenEducation:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.